About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
BOARD MEETINGS
Board
Meetings
Asarfi Hospital Ltd.
From Date
:
To Date
:
Source Date
Board Meeting Date
Details
23-Jan-2025
31-Jan-2025
Quarterly Results
22-Oct-2024
30-Oct-2024
Half Yearly Results
13-Aug-2024
20-Aug-2024
A.G.M.
30-Apr-2024
06-May-2024
Audited Results
06-Nov-2023
13-Nov-2023
Half Yearly Results
11-Aug-2023
19-Aug-2023
A.G.M. & Inter alia, to consider and approve:- 1. To hold 18th Annual General Meeting (AGM) of the Company on Friday, September 15, 2023, at 12:00 Noon at the registered office of the Company. 2. To approve the book Closure dates for the purpose of AGM of the Company from September 09th, 2023 to September 15th 12023 (both days inclusive). 3. Notice of the Annual General Meeting 4. Acceptance of resignation letter of Statutory Auditor D. N. Dokania & Associates (FRN: 050042C) Chartered Accountant. 5. Appointment of M/s R K Thakkar & Co. (FRN: 002690C), Chartered Accountant to fill the casual vacancy subject to the approval of members in the General Meeting. 6. Regularization of Mr. Gopal Singh (DIN: 01608342) as Executive Director of the Company subject t the approval of members. 7. Increase in Remuneration of Mr. Udai Pratap Singh (DIN: 08453794) from Rs. 75000.00 per month to Rs. 200000.00 per month. 8. Increase in remuneration of Mr. Harendra Singh (PAN: BANPS9243R) from Rs. 2.25 lakh to Rs. 3.5 lakh per month.
Page
1
of
1
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.